IOM report recommends abandoning US FDA 510(k) process in favour of new framework; industry concerned
This article was originally published in RAJ Devices
The US Institute of Medicine is urging the Food and Drug Administration to scrap its 35-year old 510(k) process for clearing medium- and low-risk medical devices in favour of a new regulatory framework for Class II (medium-risk) devices1.
You may also be interested in...
Work and movement-related restrictions are affecting the ability of companies to provide a timely response to questions relating to their prequalification dossiers.
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.